Results 141 to 150 of about 5,278 (198)

Failure Mode and Effect Analysis (FMEA) Over the WWW

The International Journal of Advanced Manufacturing Technology, 2000
Over the last two decades or so, good design practices have been formalised into a suite of techniques and methods — design tools. Some examples include Quality Function Deployment (QFD), Functional Analysis (as used in Value Analysis), Failure Mode and Effect Analysis (FMEA), Fault Tree Analysis (FTA), Design for Manufacture and Assembly (DFMA), and ...
Shi, J, Mak, KL, Huang, GQ
openaire   +3 more sources

Failure mode and effect analysis (FMEA) of radiotherapy

Emerald Emerging Markets Case Studies, 2020
Learning outcomes Learning outcomes are as follows: students will discover the importance of process orientation in management; students will determine the root cause of the problem by applying root cause analysis technique; students will identify the failure modes, analyze their effect, score them on a scale and prioritize the corrective action to ...
Rajaram Govindarajan   +1 more
openaire   +1 more source

Failure mode and effects analysis by data envelopment analysis

open access: yesDecision Support Systems, 2009
Failure mode and effects analysis (FMEA) is a method that examines potential failures in products or processes and has been used in many quality management systems. One important issue of FMEA is the determination of the risk priorities of failure modes.
Jian-Bo Yang   +2 more
exaly   +2 more sources

Failure Mode and Effect Analysis (FMEA)

2019
The failure mode and effect analysis (FMEA) is a technique used to identify and prevent various problems related to systems, designs, and processes. The main purpose of the technique is to increase the level of service offered to the customer, eliminate or reduce costs, increase safety, enhance corporate image through a detailed and stable quality ...
Marco Sartor, Erik Cescon
openaire   +1 more source

Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic Proteins

Journal of Pharmaceutical Sciences, 2020
Biotherapeutic drugs made by cell-based systems are revolutionizing the practice of medicine. The next generation of biotherapeutics include recombinant proteins, monoclonal antibodies, viral vector expressed proteins, and cell therapies. Immunogenicity associated adverse events is one of the major risks for these biologics.
Narendra, Chirmule   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy